Ask which mushrooms are best for heart health and most lists will name Reishi, Lion's mane, Cordyceps militaris and Chaga. The human studies point somewhere less exciting: ordinary mushrooms eaten as food, especially oyster and Shiitake, have the most data in people, and even that data is modest. The supplement with the most placebo-controlled heart research, Reishi, didn't beat placebo on cholesterol or blood pressure. This guide ranks the options by the quality of human evidence, not by marketing, and shows where to read more about each one.
No mushroom has been shown to prevent or treat heart disease. Three systematic reviews of mushroom eating (Krittanawong 2021, Uffelman 2023, Hong 2024) found hints of better triglycerides and inflammation markers but no consistent link with heart attacks, stroke or cardiovascular death. In US national data, people who ate mushrooms had a 16% lower risk of death from any cause, but no significant difference in heart deaths specifically (Ba 2021). Oyster mushroom trials suggest small lipid benefits at high risk of bias, and the best-designed recent trial found no change in LDL cholesterol (Johnen 2026). A Cochrane review found no effect of Reishi on blood pressure, cholesterol or triglycerides (Klupp 2015). The practical answer is to eat mushrooms as part of a heart-healthy diet, and to talk to your doctor before taking mushroom extracts alongside statins, blood thinners or blood pressure medicines.
This article is general information, not medical advice. If you have high blood pressure, high cholesterol, a heart condition or take cardiovascular medicines, don't start, stop or replace any treatment because of a supplement. Talk to your doctor or pharmacist first.
How Did We Rank These Mushrooms?
We sorted each mushroom by the best human evidence available for markers your doctor actually measures: LDL cholesterol, triglycerides, HDL cholesterol, blood pressure, and hard outcomes such as heart attack, stroke and cardiovascular death. Animal and cell studies count for less, because mushroom compounds that lower cholesterol in rats or calm inflammation in a dish very often don't do the same in people at realistic doses.
That rule changes the list a lot. Several famous "heart mushrooms" drop down, and the humble button and oyster mushroom move up, simply because someone has actually fed them to people and measured the results.
We also kept each section short where a dedicated article already exists. If you want the mechanism details for one species, follow the links rather than reading a repeat here.
Does Eating Mushrooms Lower Heart Disease Risk?
Probably not by much, as far as anyone can currently tell, though it may help in other ways. This is the largest body of human data, and it comes from three systematic reviews and several long-running cohort studies.
What do the systematic reviews say?
Krittanawong and colleagues, writing in the American Journal of Medicine in 2021, found 7 prospective studies on edible mushrooms and cardiovascular risk. Mushroom eating may have favourable effects on lipid profiles and was probably associated with lower mean blood pressure, but links with overall cardiovascular risk, stroke and coronary artery disease were not consistent. Their conclusion was that mushrooms have not been shown to conclusively affect cardiovascular risk factors (Krittanawong 2021).
Uffelman and colleagues reviewed 22 articles in 2023: 11 experiments and 11 observational studies. The limited experimental evidence suggested mushrooms lowered triglycerides and hs-CRP, an inflammation marker, but not other blood lipids, glucose control or blood pressure. The observational studies showed no association with total or LDL cholesterol or with death or illness from cardiovascular disease. Most of the articles were rated "poor" for quality (Uffelman 2023).
A third review in 2024, limited to 5 prospective cohorts and 4 clinical trials in the general population, again found no association between mushroom eating and cardiovascular disease, stroke or type 2 diabetes, with only suggestive links for blood glucose, HDL-related indices, hs-CRP and body weight (Hong 2024).
What about living longer?
This is where the most-quoted numbers come from. In NHANES III, 15,546 US adults were followed for an average of 19.5 years. People who reported eating mushrooms had a 16% lower risk of death from any cause than those who didn't (hazard ratio 0.84). But when the researchers looked at specific causes of death, including cardiovascular, none of the associations was statistically significant. Swapping one daily serving of processed or red meat for one serving of mushrooms was linked to a 35% lower risk of death from any cause (Ba 2021, NHANES III).
The same team then pooled their newer NHANES data with four other cohorts, covering 601,893 people. Mushroom eaters had a 6% lower risk of all-cause death (pooled risk ratio 0.94) (Ba 2021, meta-analysis). These are associations. People who eat mushrooms may differ in many ways that statistics can't fully remove, and none of this shows that mushrooms protect the heart directly.
Is there a heart-specific compound worth knowing?
Ergothioneine, an antioxidant that mushrooms contain in unusually large amounts, is the most interesting lead. In the Swedish Malmö Diet and Cancer study, 3,236 people without heart disease had their blood metabolites measured and were followed for a median of 21.4 years. Higher blood ergothioneine was associated with a lower risk of coronary disease (hazard ratio 0.85 per standard deviation) and of cardiovascular death (0.79) (Smith 2020). It was also the strongest marker of a health-conscious eating pattern, so it may partly be a sign of a good diet overall rather than a cause. Our ergothioneine guide explains what's known and what isn't.
Did a controlled feeding trial confirm it?
One good test exists. In a 2024 randomized trial, 60 middle-aged adults without cardiometabolic disease ate a Mediterranean-style diet for 8 weeks, with all food provided. Half also ate 84 g a day of white button and oyster mushrooms. The mushroom group improved fasting glucose slightly, but blood pressure, cholesterol, triglycerides and the other cardiometabolic markers did not change compared with the same diet without mushrooms (Uffelman 2024). The Mediterranean diet itself lowered total cholesterol in both groups.
The fair summary: mushrooms are a sensible part of a heart-friendly diet, especially as a swap for processed meat, but they aren't a cardiovascular treatment.
Oyster Mushroom: The Best-Studied Heart Food
Oyster mushroom (Pleurotus ostreatus) has the most clinical trials aimed at cardiometabolic markers. A 2020 systematic review found eight trials, several reporting lower total cholesterol, LDL cholesterol or triglycerides, and some reporting lower blood pressure. Body weight didn't change. Most trials had a high or unclear risk of bias, and the authors rated the evidence as low (Dicks 2020).
Oyster mushrooms also contain lovastatin, the same molecule as an early prescription statin, which was found in their fruiting bodies in the 1990s (Gunde-Cimerman 1995). That's a laboratory finding about the mushroom's chemistry, not proof that eating them lowers cholesterol like a drug.
The best-designed trial so far tempered expectations. In a 2026 double-blind randomized trial, 46 adults with moderately raised LDL cholesterol (116 to 190 mg/dL) drank 8.4 g of oyster mushroom powder a day, providing 3 g of beta-glucans, or a matching drink without it, for 4 weeks. LDL cholesterol didn't change, and neither did other lipids. Markers of cholesterol absorption did fall after adjustment for sex, mainly in women (Johnen 2026). Four weeks is short, but this is the kind of trial that the earlier positive studies needed and didn't have.
We don't sell oyster mushrooms. They're cheap and widely available fresh, which is the form most of the trials used.
Shiitake: Eritadenine and One Small Trial
Shiitake (Lentinula edodes) is known for eritadenine, a compound that lowers cholesterol in animal studies. We cover the mechanism, serving sizes and how to cook it into your diet in our Shiitake, eritadenine and cholesterol guide, so we won't repeat it here.
On the human side, the evidence is thin. In a double-blind randomized trial, 68 people with borderline high cholesterol, LDL or triglycerides ate bars containing Shiitake or placebo bars. After 66 days, the Shiitake group's triglycerides were 10% lower, and some markers of oxidative stress improved (Spim 2021). The trial was small and short, and some participants developed shiitake dermatitis, a known skin reaction to the mushroom. It's a reasonable reason to cook with Shiitake, not a reason to rely on it.
Reishi: Popular, but the Controlled Trials Disappoint
Reishi (Ganoderma lucidum) is the mushroom most often sold for the heart, and it's also the one with the most direct placebo-controlled testing. The results haven't been kind.
A 2015 Cochrane review found five trials with 398 participants. In the three that could be analysed, people took 1.4 to 3 g of Reishi a day or placebo for 12 to 16 weeks. Reishi didn't significantly change total cholesterol, LDL cholesterol, blood pressure or triglycerides. Those three trials were all in people with type 2 diabetes, so the results may not apply to everyone, but the authors concluded the evidence did not support Reishi for treating cardiovascular risk factors (Klupp 2015).
A separate double-blind crossover trial gave 1.44 g of Reishi a day to 26 people with borderline high blood pressure or cholesterol for 12 weeks. Blood pressure and body weight did not change. Insulin and insulin resistance were somewhat lower, and triglycerides and HDL looked better in the first treatment period, but carry-over effects stopped the researchers from analysing those lipids fully (Chu 2012).
Older Russian and Japanese studies are sometimes quoted for large blood pressure drops. Our article on Reishi and high blood pressure walks through those studies and the newer trials together. Our view after the Cochrane review: Reishi may have other reasons to be taken, but heart health isn't the strongest one.
Lion's mane, Cordyceps militaris and Chaga: Mostly Lab Data
These three are frequently listed as heart mushrooms, and their cardiovascular evidence is almost entirely from animal or cell studies.
Lion's mane
Lion's mane is studied in the lab for LDL oxidation and cholesterol synthesis enzymes, and for lipid changes in rodents. Our Lion's mane and cholesterol article covers each of those studies and is clear about the missing human trials. Its best human evidence is for other uses, not for the heart.
Cordyceps militaris
Cordyceps militaris contains cordycepin and is studied for blood vessel function and oxygen use during exercise. Most of the vascular data are preclinical, and much of the human research on Cordyceps used a different species, Cordyceps sinensis. Our Cordyceps militaris and vascular health article explains what the human studies actually measured.
Chaga
Chaga is rich in antioxidants and is marketed for circulation, but we're not aware of human trials testing it on blood pressure, cholesterol or heart outcomes. It can also be very high in oxalate: one case report linked long-term Chaga powder use to kidney failure from oxalate deposits (Lee 2020). That matters for people with kidney problems, which often go together with heart disease.
Evidence at a Glance
| Mushroom | Best human evidence | What changed | What didn't | Evidence level |
|---|---|---|---|---|
| Mushrooms as food (button, oyster and others) | 3 systematic reviews; large cohorts; one 8-week randomized feeding trial | Lower all-cause death in cohorts; possible triglyceride and hs-CRP benefits; slight glucose improvement | No consistent link with cardiovascular death, heart disease or stroke; no change in blood pressure or cholesterol in the feeding trial | Moderate for diet use, low for heart effects |
| Oyster mushroom | 8 trials (high risk of bias); one 2026 double-blind trial | Lipid and blood pressure reductions in older trials | No LDL change in the best-designed trial | Low |
| Shiitake | One small double-blind trial (68 people) | Triglycerides about 10% lower after 66 days | Too small and short to judge LDL or heart outcomes | Low |
| Reishi | Cochrane review (5 trials); one crossover trial | Possible small insulin effects | Cholesterol, LDL, blood pressure and triglycerides vs placebo | Low, mostly negative |
| Lion's mane, Cordyceps militaris, Chaga | Animal and cell studies | Lab markers only | No controlled human heart trials we could rely on | Very low |
Is It Safe to Combine Mushrooms With Heart Medicines?
Culinary mushrooms in normal food amounts are not a known problem for people on heart medicines. Concentrated extracts are a different matter, and three groups of drugs deserve a conversation with your doctor or pharmacist first.
Blood thinners and antiplatelet drugs
A case report described a rise in INR, a measure of how long blood takes to clot, in a patient taking maitake extract with warfarin (Hanselin 2010). In laboratory tests, hot water extracts of several edible mushrooms, including wood ear, king oyster and Reishi, reduced platelet clumping, although none changed standard clotting tests (Poniedziałek 2019). That's test-tube data, but it's enough reason to tell your prescriber before adding an extract to warfarin, a DOAC, aspirin or clopidogrel. Our maitake interactions guide covers the warfarin case in more detail.
Blood pressure medicines
Claims that Reishi or Cordyceps "add to" blood pressure drugs are mostly theoretical; the controlled Reishi trials above found no blood pressure effect. Our article on mushrooms and blood pressure medication separates what is documented from what is assumed, including why kidney function matters.
Statins
Oyster mushrooms naturally contain lovastatin. Eating them as food is not known to cause problems, but concentrated oyster mushroom products on top of a prescribed statin haven't been studied for safety. Don't use any mushroom product as a replacement for a statin your doctor has prescribed.
For a wider view across drug classes, see our guide to mushroom supplements and medication interactions.
What Is the Sensible Way to Use Mushrooms for Your Heart?
- Treat them as food first. The strongest human signal is for eating mushrooms, particularly in place of processed or red meat, within an overall healthy diet.
- Know your numbers. If you try a mushroom product for cholesterol, get a lipid panel before you start and again after about three months, so you're judging by results, not hope.
- Don't stack extracts. Combining several concentrated mushroom products makes it harder to spot side effects and interactions.
- Bring the label to your doctor. This matters most if you take a statin, a blood thinner, an antiplatelet drug or blood pressure medication, or if you have kidney disease.
- Never swap a prescription for a supplement. No mushroom has been shown to replace statins, antihypertensives or anticoagulants.
Frequently Asked Questions
What is the best mushroom for heart health?
Based on human studies, ordinary edible mushrooms eaten as food, such as oyster, button and Shiitake, have the most supportive evidence, and that evidence is modest. Among supplements, none has convincing placebo-controlled evidence for lowering cholesterol or blood pressure.
Do mushrooms lower cholesterol?
Some oyster mushroom trials reported lower total and LDL cholesterol, but they had a high risk of bias, and a 2026 double-blind trial found no change in LDL after four weeks. Reviews of mushroom eating mostly show possible effects on triglycerides rather than LDL.
Is Reishi good for blood pressure?
In the placebo-controlled trials pooled by Cochrane and in a separate crossover trial, Reishi did not lower blood pressure. If your blood pressure is high, follow your doctor's treatment plan.
Can I take mushroom supplements with statins or blood thinners?
Ask your doctor or pharmacist first. Food amounts aren't a known concern, but concentrated extracts may affect platelets or clotting, and a case report linked maitake extract with a rise in INR on warfarin.
How many mushrooms should I eat for my heart?
There's no proven heart dose. In the US cohort data, a daily serving was used as the comparison unit, and the 2024 feeding trial used 84 g a day. A serving a day within a balanced diet is a reasonable food habit, not a treatment.
Shop Heart-Friendly Mushrooms
If you want to put the food-first evidence into practice, our dried organic Shiitake (50 g €39) is made for cooking, soups and broths. Our Forest Cardio Power capsules (120 caps €49) combine turmeric extract with Cordyceps militaris and are designed for active people. Neither is a treatment for heart disease.
Related Articles
- Shiitake for Cholesterol: Eritadenine and Diet Integration
- Reishi and High Blood Pressure
- Lion's Mane and Cholesterol: What the Research Shows
- Cordyceps Militaris Benefits for Vascular Health
- Ergothioneine: The Antioxidant Your Body Collects
- Mushrooms and Blood Pressure Medication
- Mushroom Supplements and Medication Interactions
Sources
- Krittanawong C, Isath A, Hahn J, Wang Z, Fogg SE, Bandyopadhyay D, et al. Mushroom Consumption and Cardiovascular Health: A Systematic Review. Am J Med. 2021;134(5):637-642.e2. PubMed 33309597
- Uffelman CN, Chan NI, Davis EM, Wang Y, McGowan BS, Campbell WW. An Assessment of Mushroom Consumption on Cardiometabolic Disease Risk Factors and Morbidities in Humans: A Systematic Review. Nutrients. 2023;15(5):1079. PubMed 36904079
- Hong JY, Kim MK, Yang N. Mushroom consumption and cardiometabolic health outcomes in the general population: a systematic review. Nutr Res Pract. 2024;18(2):165-179. PubMed 38584813
- Ba DM, Gao X, Muscat J, Al-Shaar L, Chinchilli V, Zhang X, et al. Association of mushroom consumption with all-cause and cause-specific mortality among American adults: prospective cohort study findings from NHANES III. Nutr J. 2021;20(1):38. PubMed 33888143
- Ba DM, Gao X, Al-Shaar L, Muscat J, Chinchilli VM, Ssentongo P, et al. Prospective study of dietary mushroom intake and risk of mortality: results from continuous National Health and Nutrition Examination Survey (NHANES) 2003-2014 and a meta-analysis. Nutr J. 2021;20(1):80. PubMed 34548082
- Smith E, Ottosson F, Hellstrand S, Ericson U, Orho-Melander M, Fernandez C, et al. Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart. 2020;106(9):691-697. PubMed 31672783
- Uffelman CN, Schmok JN, Campbell RE, Hartman AS, Olson MR, Anderson NL, et al. Consuming Mushrooms When Adopting a Healthy Mediterranean-Style Dietary Pattern Does Not Influence Short-Term Changes of Most Cardiometabolic Disease Risk Factors in Healthy Middle-Aged and Older Adults. J Nutr. 2024;154(2):574-582. PubMed 38135005
- Dicks L, Ellinger S. Effect of the Intake of Oyster Mushrooms (Pleurotus ostreatus) on Cardiometabolic Parameters: A Systematic Review of Clinical Trials. Nutrients. 2020;12(4):1134. PubMed 32316680
- Johnen J, Waizenegger J, Ellinger J, Lütjohann D, Steffens KE, Wagner KG, et al. Effects of regular consumption of a β-glucan-rich oyster mushroom powder on cholesterol metabolism in adults with moderately elevated LDL-cholesterol concentrations: a double-blind randomized controlled trial. Nutr Metab (Lond). 2026;23(1). PubMed 42071226
- Gunde-Cimerman N, Cimerman A. Pleurotus fruiting bodies contain the inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase-lovastatin. Exp Mycol. 1995;19(1):1-6. PubMed 7614366
- Spim SRV, Pistila AMH, Pickler TB, Silva MT, Grotto D. Effects of Shiitake Culinary-Medicinal Mushroom, Lentinus edodes (Agaricomycetes), Bars on Lipid and Antioxidant Profiles in Individuals with Borderline High Cholesterol: A Double-Blind Randomized Clinical Trial. Int J Med Mushrooms. 2021;23(7):1-12. PubMed 34375514
- Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, et al. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;(2):CD007259. PubMed 25686270
- Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr. 2012;107(7):1017-27. PubMed 21801467
- Hanselin MR, Vande Griend JP, Linnebur SA. INR elevation with maitake extract in combination with warfarin. Ann Pharmacother. 2010;44(1):223-4. PubMed 20040699
- Poniedziałek B, Siwulski M, Wiater A, Komaniecka I, Komosa A, Gąsecka M, et al. The Effect of Mushroom Extracts on Human Platelet and Blood Coagulation: In vitro Screening of Eight Edible Species. Nutrients. 2019;11(12):3040. PubMed 31842490
- Lee S, Lee HY, Park Y, Ko EJ, Ban TH, Chung BH, et al. Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature. J Korean Med Sci. 2020;35(19):e122. PubMed 32419395

